• Eliminating Pollen Spectral Interference in Bioaerosol Detec

  2026-06-03

  This study presents a novel approach to remove pollen-induced spectral interference in excitation emission matrix (EEM) fluorescence spectroscopy, significantly improving the classification accuracy of hazardous bioaerosols. These findings enhance rapid, reliable detection of bacterial and toxic agents in complex environmental samples, supporting public health monitoring.

• Aprotinin: Applied Workflows for Fibrinolysis Inhibition Res

  2026-06-03

  Aprotinin (bovine pancreatic trypsin inhibitor) delivers precise, reversible serine protease inhibition for blood management and mechanistic studies in cardiovascular research. Discover data-driven protocols, experimental enhancements, and troubleshooting insights to maximize reproducibility and translational relevance using APExBIO’s trusted reagent.

• LY364947: Applied Workflows for TGF-β Type I Receptor Kinase

  2026-06-02

  LY364947 empowers researchers with selective, reproducible inhibition of the TGF-β type I receptor kinase. This guide translates recent advances—including synergistic EMT modulation and robust assay protocols—into actionable workflows and troubleshooting strategies for cutting-edge fibrosis, cancer, and retinal degeneration research.

• Cholesterol Impedes Intracellular Trafficking of Lipid Nanop

  2026-06-02

  This study provides mechanistic insight into how cholesterol content within lipid nanoparticles (LNPs) hinders the intracellular trafficking and delivery efficiency of nucleic acid cargos. The findings have direct implications for the rational design of LNP-based delivery systems in molecular biology and therapeutic contexts.

• EZ Cap EGFP mRNA 5-moUTP: Advancing Translation Efficiency A

  2026-06-01

  EZ Cap™ EGFP mRNA (5-moUTP) sets a new standard for gene expression studies, combining robust translation, immune evasion, and superior stability. This APExBIO solution empowers workflows from mRNA delivery optimization to in vivo imaging, with practical protocols and troubleshooting strategies for reproducible results.

• Hematoxylin and Eosin Staining Kit: Protocol and QC Guide

  2026-06-01

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) provides an efficient, ready-to-use solution for visualizing cellular and tissue morphology in histopathological and cytological research. It is optimized for both paraffin-embedded and frozen tissue sections but is not suitable for diagnostic or medical applications.

• ATRX-Deficient Glioma Sensitivity to Selective PDGFR Inhibit

  2026-05-31

  The referenced study uncovers that ATRX-deficient high-grade glioma cells are particularly vulnerable to receptor tyrosine kinase and selective PDGFR inhibitors. This finding suggests that ATRX status could be a key stratification factor for optimizing targeted therapies and interpreting clinical trial outcomes in glioma research.

• Bending Rigidity of Red Blood Cell Membranes: New Quantitati

  2026-05-30

  This study provides a direct measurement of the bending modulus of the red blood cell cytoplasmic membrane, excluding contributions from the spectrin network and ATP. Using advanced scattering and simulation techniques, the authors report a notably low bending rigidity (4–6 kBT), offering fresh perspectives on red blood cell mechanical properties and their biological implications.

• NMDA (N-Methyl-D-aspartic acid) in Excitotoxicity Research

  2026-05-29

  NMDA (N-Methyl-D-aspartic acid) is the gold-standard NMDA receptor agonist for modeling excitotoxicity, calcium influx, and oxidative stress in neurodegenerative disease research. Learn how to leverage APExBIO’s high-purity NMDA for reproducible workflows, nuanced troubleshooting, and experimental designs inspired by the latest advances in glaucoma and retinal ganglion cell studies.

• Caspase-4 Colorimetric Assay: Driving Translational Pyroptos

  2026-05-29

  Explore the mechanistic, technical, and translational frontiers of caspase-4 biology and pyroptosis with a deep dive into LEVD-dependent enzyme assays. This article delivers strategic guidance for researchers seeking to bridge bench and bedside in inflammation and cell fate modulation, highlighting the pivotal role of APExBIO’s Caspase-4 Colorimetric Assay Kit in advancing biomarker detection and experimental rigor.

• Isoliensinine Mitigates LPS-Induced Neuroinflammation via MA

  2026-05-28

  This study reveals that isoliensinine, a bisbenzylisoquinoline alkaloid, confers neuroprotection by attenuating LPS-induced neuroinflammation in microglia through inhibition of the MAPK/NF-κB pathway. The findings highlight isoliensinine's impact on oxidative stress and mitochondrial dysfunction, supporting its potential as a candidate for further research in Alzheimer's disease models.

• Antidepressant Effects of Rotigotine in Experimental Depress

  2026-05-28

  This study demonstrates that rotigotine, a dopamine D2/D3 receptor agonist, possesses antidepressant-like properties in validated rodent models of depression, with efficacy at sub-hyperlocomotor doses. These results highlight the compound's potential to address depressive symptoms that frequently overlap with Parkinson's disease, expanding its relevance beyond traditional antiparkinsonian use.

• Acifran: Precision Tool for Lipid Metabolism Research Workfl

  2026-05-27

  Acifran, a selective HM74A/GPR109A and GPR109B agonist, unlocks new precision in lipid metabolism research with structural validation and robust assay performance. Its unique profile empowers advanced GPCR signaling studies and next-generation metabolic disorder research. Discover protocol enhancements, troubleshooting strategies, and practical insights for maximizing its impact.

• Crystal Violet Staining Solution: Precision in Nuclear Stain

  2026-05-27

  Crystal Violet Staining Solution empowers researchers to achieve robust, reproducible nuclear staining in cell-based and tissue assays. By optimizing protocol parameters and understanding comparative dye performance, scientists can maximize data clarity and troubleshoot workflow bottlenecks in both classic and advanced experimental setups.

• Praeruptorin A Inhibits HCC Metastasis via ERK/MMP1 Modulati

  2026-05-26

  This study demonstrates that praeruptorin A suppresses migration and invasion in human hepatocellular carcinoma (HCC) cells by downregulating MMP1 through ERK pathway activation. The results highlight a mechanistically distinct, non-cytotoxic approach to targeting HCC metastasis, providing a promising direction for future hepatoprotective agent development.

11730 records 1/782 page Next 12345 下5页 Last page